BioSpace News Archive

On November 15, 2018, William A. Brandt, Jr., of Development Specialists, Inc., Receiver of 3si Systems, LLC and its assets, will sell all of the technology and assets related to a Hospital Operating Room Voice Command System (the “Voice Command System”)

Spero Health, Inc., a newly formed healthcare organization specializing in local, affordable, outpatient care for individuals suffering from substance use disorder, announced that it has acquired investment growth capital to meet the demand in communities across the country for high-quality, comprehensive and integrated addiction treatment services.

IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, today announced a collaborative paper published in Nature Communications1 with the Technical University of Denmark, and the Instituto Clodomiro Picado of the University of Costa Rica describing the development of a panel of human antibodies that neutralise elements of black mamba snake toxin in an in vivo model.

Dr. Michael Frunzi, Product Manager, Optical Products for Smiths Detection, testified on technology’s role in interdicting opioids and other dangerous narcotics.

Maxor National Pharmacy Services, LLC (“Maxor”) announced its results from the 2018 Pharmacy Benefit Manager Customer Satisfaction Report, published by the Pharmacy Benefit Management Institute® (PBMI). MaxorPlus received the highest Overall Satisfaction score of 9.6 out of 10, exceeding the average score of all PBMs profiled in the report.

iHerb announces the opening of the company’s fifth distribution center in early 2019. iHerb’s fifth and newest distribution center is located in Easton, Pennsylvania and is the company’s fourth distribution center on the East Coast of the U.S.

2018 ACR/ARHP Annual Meeting being held in Chicago, IL, October 19 - 24

Health Canada has granted Brain Armor an NHP License for their premium line of brain health supplements

Predictive Technology Group, Inc. (OTC/PINK: PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through unique biotechnology treatments, announces that it has acquired DNA and ancestry assets, including significant genetic data related to women’s diseases and degenerative disc disease from Taueret Laboratories, LLC

Teligent (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug application (ANDA) from the Food and Drug Administration (FDA) of Fluocinonide Ointment USP, 0.05%.